《滬深兩市》上證深成半日升0.4%-0.7% 創板先跌後回穩 中移動漲停 藥明康德續跌4%
內地昨日(8日)新增本土確診病例73例。人行今日(9日)進行200億人民幣(下同)7天期逆回購操作,利率持平。人民幣兌美元中間價今下調84點。上證深成微微低開後反覆向好,創板曾跌近1%後回穩。
上證低見3,444,半日反覆倒升13點或0.4%,近高收報3,466點;深成指升90點或0.7%,收報13,416點;創業板指數靠穩平收報2,846點,成交1,239億元。上證深成半日成交分別爲2,372億元及3,321.5億元。
中資金融股偏軟,工行(601398.SH)及建行(601939.SH)分別跌0.4%及0.8%。華夏幸福(600340.SH)續升4.6%。中移動(600941.SH)持續強勢,今早漲停造67.43元。
部份煤炭股上揚,兗礦能源(600188.SH)及山西焦煤(000983.SZ)分別升4.6%及3.5%。
鋰電池概念股走高,西藏礦業(000762.SZ)、西藏城投(600773.SH)及西藏珠峯(600338.SH)升3.4%-8%。惟寧德時代(300750.SZ)偏軟跌0.9%。比亞迪(002594.SZ)則升2.5%。
白酒股貴州茅臺(600519.SH)升1.2%。口子窖(603589.SH)漲停。
藥明康德A股(603259.SH)續跌4%,公司昨日指未被美列入未經覈實名單。(ta/k) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.